Register for Updates

INDICATION

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Register for Updates

Want to stay up to date on DESCOVY FOR PrEP and relevant information as it becomes available?

Register and we'll send updates as new information becomes available.

*Indicates required field.

Please fix the error below.

Please fix the errors below.

Terms and Conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials about DESCOVY and other updates, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. Review our Privacy Policy for more information.